Severn Trent PLC (LON:SVT – Get Free Report) insider Thomas (Tom) Delay purchased 300 shares of the stock in a transaction dated Monday, June 9th. The shares were acquired at an average price of GBX 2,653 ($36.12) per share, with a total value of £7,959 ($10,835.94).
Severn Trent Price Performance
SVT stock opened at GBX 2,727.42 ($37.13) on Friday. The business’s fifty day moving average price is GBX 2,685.64 and its 200 day moving average price is GBX 2,568.74. Severn Trent PLC has a 12-month low of GBX 2,323 ($31.63) and a 12-month high of GBX 2,807 ($38.22). The company has a market capitalization of £8.14 billion, a PE ratio of 45.52, a P/E/G ratio of 4.69 and a beta of 0.38. The company has a current ratio of 2.14, a quick ratio of 0.73 and a debt-to-equity ratio of 450.94.
Severn Trent (LON:SVT – Get Free Report) last issued its quarterly earnings results on Wednesday, May 21st. The company reported GBX 112.10 ($1.53) earnings per share (EPS) for the quarter. Severn Trent had a net margin of 6.00% and a return on equity of 10.40%. On average, sell-side analysts anticipate that Severn Trent PLC will post 107.3706004 EPS for the current year.
Analyst Ratings Changes
About Severn Trent
As one of Britain’s largest water companies, we provide over eight million people across our region with fresh, clean drinking water – about two billion litres every day. And when they’ve finished with it, we take it away again then clean and treat it before returning it safely back to the environment.
We are one of only three listed water stocks in the UK, offering a valuable combination of reliable earnings, long term asset growth and an inflation-linked dividend.
Featured Articles
- Five stocks we like better than Severn Trent
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- With Risk Tolerance, One Size Does Not Fit All
- 3 Stocks Set to Double—And There’s Still Time to Buy
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Severn Trent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Severn Trent and related companies with MarketBeat.com's FREE daily email newsletter.